Gene regulatory networks (GRNs) have always been fundamental in the study of basic biology and drug development. With advancements in technologies like single cell sequencing, the granularity and precision of GRNs have drastically improved, and so has the potential for impactful advancements in drug development. Such advancements have only been made possible through the use of machine learning. As the third in a sequence of symposiums focusing on machine learning applied to immunology, biology, and medicine, this symposium brings together leaders in the field to discuss the topic of GRNs.



